A phase I‐II design based on periodic and continuous monitoring of disease status and the times to toxicity and death-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase I‐II design based on periodic and continuous monitoring of disease status and the times to toxicity and death

Published:2020-04-07 Issue:15 Volume:39 Page:2035-2050
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Lee Juhee¹^ORCID,F. Thall Peter²,Msaouel Pavlos³

Affiliation:

1. Department of Statistics University of California Santa Cruz Santa Cruz California USA

2. Department of Biostatistics The University of Texas MD Anderson Cancer Center Houston Texas USA

3. Department of Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA

Funder

Conquer Cancer Foundation

Division of Mathematical Sciences

Kidney Cancer Association

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.8528

Reference30 articles.

1. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

2. Sitravatinib potentiates immune checkpoint blockade in refractory cancer models

3. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

4. The bivariate continual reassessment method

5. Dose-Finding Based on Efficacy-Toxicity Trade-Offs

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A generalized phase 1-2-3 design integrating dose optimization with confirmatory treatment comparison;Biometrics;2024-01-29

2. Risk–benefit trade-offs and precision utilities in phase I-II clinical trials;Clinical Trials;2023-12-18

3. Interpreting Randomized Controlled Trials;Cancers;2023-09-22

4. Generalized phase I‐II designs to increase long term therapeutic success rate;Pharmaceutical Statistics;2023-04-11

5. Confirmatory adaptive group sequential designs for single‐arm phase II studies with multiple time‐to‐event endpoints;Biometrical Journal;2021-07-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3